publication venue for
- Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab. 2022
- Twists and turns from "tumor in tumor" profiling: surveillance of chronic lymphocytic leukemia (CLL) leads to detection of a lung adenocarcinoma, whose genomic characterization alters the original hematologic diagnosis. 2021
- Diffuse midline glioma with novel, potentially targetable, FGFR2-VPS35 fusion. 2020
- A case of KMT2A-SEPT9 fusion-associated acute megakaryoblastic leukemia. 2018
- A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma. 2018
- Exceptional response to everolimus in a novel tuberous sclerosis complex-2 mutation-associated metastatic renal-cell carcinoma. 2018
- Germline BRCA2 mutations detected in pediatric sequencing studies impact parents' evaluation and care. 2017
- A novel, potentially targetable TMEM106B-BRAF fusion in pleomorphic xanthoastrocytoma. 2017
- Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response. 2016
- Whole-genome characterization of myoepithelial carcinomas of the soft tissue.. 8. 2022
- Whole-exome sequencing detects PYGM variants in two adults with McArdle disease.. 8. 2022
- Novel MYO5B Mutation in Microvillous Inclusion Disease of Syrian Ancestry. 2021
- Exceptional responders with invasive mucinous adenocarcinomas: a phase 2 trial of bortezomib in patients with KRAS G12D-mutant lung cancers.. 5. 2019
- Germline SDHA mutations in children and adults with cancer.. 4. 2018
- A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.. 3. 2017
- Characterization of a novel fusion gene EML4-NTRK3 in a case of recurrent congenital fibrosarcoma.. 1. 2015
- Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.. 1. 2015
- Myeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay.. 1. 2015
- Precision oncogenomics in pediatrics: a personal reflection. 2018